Dr. Ayse Ece Cali Daylan, MD

Dr. Cali Daylan practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Cali Daylan's NPI, 1720509557, was assigned on July 1, 2017. Dr. Cali Daylan holds Missouri license 2023049394.

Dr. Cali Daylan's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Cali Daylan also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Cali Daylan's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. Dr. Cali Daylan is also affiliated with Missouri Baptist Medical Center. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Cali Daylan to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cali Daylan practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Cali Daylan's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Cali Daylan is licensed in Missouri.

CMS data shows 13 Medicare services from Dr. Cali Daylan across 1 procedure code in 2024, for 34 Medicare patients. Medicare paid $1,299 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 34 Medicare patients who saw Dr. Cali Daylan in 2024. The largest group is 65 to 74, with 17 patients. 75% of them have cancer, and 75% have high blood pressure. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cali Daylan's median patient age at 71, with 50% women.

In 2024, Dr. Cali Daylan wrote 74 Medicare Part D claims for 25 patients. 86% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $581 in total drug cost. In 2023, CMS named 18 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Cali Daylan for performance year 2024, reported as part of a group. Dr. Cali Daylan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 18 general payments to Dr. Cali Daylan from 9 drug and device companies from 2021 to 2024. Food and beverage make up the largest share, 90% of the total. Sanofi and Genzyme US Companies paid the most, $374.